APGE — Apogee Therapeutics Share News
0.000.00%
Last trade - 00:00NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Abbvie Seeks At Least $8 Billion In Debt To Fund Apogee Deal - Bloomberg News
Street View: Strength in AbbVie's immunology pipeline to support revenue growth
AbbVie trims 2026 profit view on Apogee deal, tops second-quarter estimates (updated)
AbbVie trims 2026 profit forecast on Apogee buy, beats second-quarter estimates
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Major deals involving US drugmakers and biotechs over the past decade
U.S. RESEARCH ROUNDUP-Bank of America, FedEx, JPMorgan
U.S. RESEARCH ROUNDUP-Apogee Therapeutics, GE Healthcare, Synopsys
US STOCKS-S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
US STOCKS-S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
Deals of the day-Mergers and acquisitions
US STOCKS-S&P 500, Nasdaq fall, dragged by Alphabet and megacap tech; focus on Iran
U.S. STOCKS ON THE MOVE-Abbvie, AMC, Getty
Deals of the day-Mergers and acquisitions
Abbvie jumps after $10.9 billion deal to buy Apogee Therapeutics
U.S. STOCKS ON THE MOVE-Getty Images, Ecarx, Maplight Therapeutics
U.S. STOCKS ON THE MOVE-Definium, Regenxbio, Arcosa
U.S. STOCKS ON THE MOVE- Visteon, Incyte, Apogee